4-Hydroxybutyric Acid
The therapeutic efficacy of Gamma Hydroxybutyric Acid can be increased when used in combination with Pregabalin.
Acarbose
The risk or severity of heart failure can be increased when Pregabalin is combined with Acarbose.
Acepromazine
The therapeutic efficacy of Acepromazine can be increased when used in combination with Pregabalin.
Advertisement
Aceprometazine
The therapeutic efficacy of Aceprometazine can be increased when used in combination with Pregabalin.
Acetazolamide
The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Pregabalin.
Acetohexamide
The risk or severity of heart failure can be increased when Pregabalin is combined with Acetohexamide.
Advertisement
Albiglutide
The risk or severity of weight gain can be increased when Pregabalin is combined with Albiglutide.
Alfaxalone
The therapeutic efficacy of Alfaxalone can be increased when used in combination with Pregabalin.
Alfentanil
The therapeutic efficacy of Alfentanil can be increased when used in combination with Pregabalin.
Advertisement
Alogliptin
The risk or severity of heart failure can be increased when Pregabalin is combined with Alogliptin.
Alphaprodine
The therapeutic efficacy of Alphaprodine can be increased when used in combination with Pregabalin.
Alprazolam
The therapeutic efficacy of Alprazolam can be increased when used in combination with Pregabalin.
Amisulpride
The therapeutic efficacy of Amisulpride can be increased when used in combination with Pregabalin.
Amitriptyline
The therapeutic efficacy of Amitriptyline can be increased when used in combination with Pregabalin.
Amobarbital
The therapeutic efficacy of Amobarbital can be increased when used in combination with Pregabalin.
Amoxapine
The therapeutic efficacy of Amoxapine can be increased when used in combination with Pregabalin.
Aripiprazole
The therapeutic efficacy of Aripiprazole can be increased when used in combination with Pregabalin.
Articaine
The therapeutic efficacy of Articaine can be increased when used in combination with Pregabalin.
Asenapine
The therapeutic efficacy of Asenapine can be increased when used in combination with Pregabalin.
Azelastine
The therapeutic efficacy of Azelastine can be increased when used in combination with Pregabalin.
Baclofen
The therapeutic efficacy of Baclofen can be increased when used in combination with Pregabalin.
Barbexaclone
The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Pregabalin.
Barbital
The therapeutic efficacy of Barbital can be increased when used in combination with Pregabalin.
Beclamide
The therapeutic efficacy of Beclamide can be decreased when used in combination with Pregabalin.
Benazepril
The risk or severity of angioedema can be increased when Benazepril is combined with Pregabalin.
Benoxinate
The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Pregabalin.
Benperidol
The therapeutic efficacy of Benperidol can be increased when used in combination with Pregabalin.
Benzocaine
The therapeutic efficacy of Benzocaine can be increased when used in combination with Pregabalin.
Benzyl Alcohol
The therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Pregabalin.
Brexpiprazole
The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Pregabalin.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Brivaracetam
The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Pregabalin.
Bromazepam
The therapeutic efficacy of Bromazepam can be increased when used in combination with Pregabalin.
Bromperidol
The therapeutic efficacy of Bromperidol can be increased when used in combination with Pregabalin.
Brompheniramine
The therapeutic efficacy of Brompheniramine can be increased when used in combination with Pregabalin.
Brotizolam
The therapeutic efficacy of Brotizolam can be increased when used in combination with Pregabalin.
Bupivacaine
The therapeutic efficacy of Bupivacaine can be increased when used in combination with Pregabalin.
Buprenorphine
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The therapeutic efficacy of Buspirone can be increased when used in combination with Pregabalin.
Butabarbital
The therapeutic efficacy of Butabarbital can be increased when used in combination with Pregabalin.
Butalbital
The therapeutic efficacy of Butalbital can be increased when used in combination with Pregabalin.
Butamben
The therapeutic efficacy of Butamben can be increased when used in combination with Pregabalin.
Butobarbital
The therapeutic efficacy of Butethal can be increased when used in combination with Pregabalin.
Butorphanol
The therapeutic efficacy of Butorphanol can be increased when used in combination with Pregabalin.
Canagliflozin
The risk or severity of heart failure can be increased when Pregabalin is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of heart failure can be increased when Pregabalin is combined with Canagliflozin.
Captopril
The risk or severity of angioedema can be increased when Captopril is combined with Pregabalin.
Carbamazepine
The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Pregabalin.
Carbinoxamine
The therapeutic efficacy of Carbinoxamine can be increased when used in combination with Pregabalin.
Carisoprodol
The therapeutic efficacy of Carisoprodol can be increased when used in combination with Pregabalin.
Cetirizine
The therapeutic efficacy of Cetirizine can be increased when used in combination with Pregabalin.
Chloral Hydrate
The therapeutic efficacy of Chloral hydrate can be increased when used in combination with Pregabalin.
Chlordiazepoxide
The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Pregabalin.
Chlormethiazole
The therapeutic efficacy of clomethiazole can be decreased when used in combination with Pregabalin.
Chlormezanone
The therapeutic efficacy of Chlormezanone can be increased when used in combination with Pregabalin.
Chloroprocaine
The therapeutic efficacy of Chloroprocaine can be increased when used in combination with Pregabalin.
Chlorpheniramine
The therapeutic efficacy of Chlorphenamine can be increased when used in combination with Pregabalin.
CHLORPHENIRAMINE POLISTIREX
The therapeutic efficacy of Chlorphenamine can be increased when used in combination with Pregabalin.
Chlorpromazine
The therapeutic efficacy of Chlorpromazine can be increased when used in combination with Pregabalin.
Chlorpropamide
The risk or severity of heart failure can be increased when Pregabalin is combined with Chlorpropamide.
Chlorprothixene
The therapeutic efficacy of Chlorprothixene can be increased when used in combination with Pregabalin.
Chlorzoxazone
The therapeutic efficacy of Chlorzoxazone can be increased when used in combination with Pregabalin.
Cilazapril
The risk or severity of angioedema can be increased when Cilazapril is combined with Pregabalin.
Citalopram
The risk or severity of adverse effects can be increased when Pregabalin is combined with Citalopram.
Clemastine
The therapeutic efficacy of Clemastine can be increased when used in combination with Pregabalin.
Clidinium
The therapeutic efficacy of Clidinium can be increased when used in combination with Pregabalin.
Clidinium bromide
The therapeutic efficacy of Clidinium can be increased when used in combination with Pregabalin.
Clobazam
The therapeutic efficacy of Clobazam can be decreased when used in combination with Pregabalin.
Clomipramine
The therapeutic efficacy of Clomipramine can be increased when used in combination with Pregabalin.
Clonazepam
The therapeutic efficacy of Clonazepam can be decreased when used in combination with Pregabalin.
Clonidine
The therapeutic efficacy of Clonidine can be increased when used in combination with Pregabalin.
Clorazepate
The therapeutic efficacy of Clorazepate can be decreased when used in combination with Pregabalin.
CLORAZEPIC ACID
The therapeutic efficacy of Clorazepate can be decreased when used in combination with Pregabalin.
Clozapine
The therapeutic efficacy of Clozapine can be increased when used in combination with Pregabalin.
Cocaine
The therapeutic efficacy of Cocaine can be increased when used in combination with Pregabalin.
Codeine
The therapeutic efficacy of Codeine can be increased when used in combination with Pregabalin.
Codeine Anhydrous
The therapeutic efficacy of Codeine can be increased when used in combination with Pregabalin.
CODEINE POLISTIREX
The therapeutic efficacy of Codeine can be increased when used in combination with Pregabalin.
Cyclizine
The therapeutic efficacy of Cyclizine can be increased when used in combination with Pregabalin.
Cyclobenzaprine
The therapeutic efficacy of Cyclobenzaprine can be increased when used in combination with Pregabalin.
Cyproheptadine
The therapeutic efficacy of Cyproheptadine can be increased when used in combination with Pregabalin.
Dantrolene
The therapeutic efficacy of Dantrolene can be increased when used in combination with Pregabalin.
Dapiprazole
The therapeutic efficacy of Dapiprazole can be increased when used in combination with Pregabalin.
Desflurane
The therapeutic efficacy of Desflurane can be increased when used in combination with Pregabalin.
Desipramine
The therapeutic efficacy of Desipramine can be increased when used in combination with Pregabalin.
Desloratadine
The therapeutic efficacy of Desloratadine can be increased when used in combination with Pregabalin.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Pregabalin is combined with Desvenlafaxine.
Dexbrompheniramine
The therapeutic efficacy of Dexbrompheniramine can be increased when used in combination with Pregabalin.
Dexmedetomidine
The therapeutic efficacy of Dexmedetomidine can be increased when used in combination with Pregabalin.
Dextromoramide
The therapeutic efficacy of Dextromoramide can be increased when used in combination with Pregabalin.
Dezocine
The therapeutic efficacy of Dezocine can be increased when used in combination with Pregabalin.
Diazepam
The therapeutic efficacy of Diazepam can be decreased when used in combination with Pregabalin.
Dibucaine
The therapeutic efficacy of Cinchocaine can be increased when used in combination with Pregabalin.
Difenoxin
The therapeutic efficacy of Difenoxin can be increased when used in combination with Pregabalin.
Dihydrocodeine
The therapeutic efficacy of Dihydrocodeine can be increased when used in combination with Pregabalin.
Dimenhydrinate
The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Pregabalin.
Diphenhydramine
The therapeutic efficacy of Diphenhydramine can be increased when used in combination with Pregabalin.
Diphenoxylate
The therapeutic efficacy of Diphenoxylate can be increased when used in combination with Pregabalin.
Dipropylacetamide
The therapeutic efficacy of Valpromide can be decreased when used in combination with Pregabalin.
Doxepin
The therapeutic efficacy of Doxepin can be increased when used in combination with Pregabalin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Dulaglutide
The risk or severity of heart failure can be increased when Pregabalin is combined with Dulaglutide.
Duloxetine
The risk or severity of adverse effects can be increased when Pregabalin is combined with Duloxetine.
Dyclonine
The therapeutic efficacy of Dyclonine can be increased when used in combination with Pregabalin.
Efavirenz
The therapeutic efficacy of Efavirenz can be increased when used in combination with Pregabalin.
Empagliflozin
The risk or severity of heart failure can be increased when Pregabalin is combined with Empagliflozin.
Enalapril
The risk or severity of angioedema can be increased when Enalapril is combined with Pregabalin.
Enalaprilat
The risk or severity of angioedema can be increased when Enalaprilat is combined with Pregabalin.
Enalaprilat Anhydrous
The risk or severity of angioedema can be increased when Enalaprilat is combined with Pregabalin.
Enflurane
The therapeutic efficacy of Enflurane can be increased when used in combination with Pregabalin.
Entacapone
The therapeutic efficacy of Entacapone can be increased when used in combination with Pregabalin.
Escitalopram
The risk or severity of adverse effects can be increased when Pregabalin is combined with Escitalopram.
Eslicarbazepine Acetate
The therapeutic efficacy of Eslicarbazepine acetate can be decreased when used in combination with Pregabalin.
Estazolam
The therapeutic efficacy of Estazolam can be decreased when used in combination with Pregabalin.
Eszopiclone
The therapeutic efficacy of Eszopiclone can be increased when used in combination with Pregabalin.
Ethanol
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The therapeutic efficacy of Ethchlorvynol can be increased when used in combination with Pregabalin.
Ethosuximide
The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Pregabalin.
Ethotoin
The therapeutic efficacy of Ethotoin can be decreased when used in combination with Pregabalin.
Ethyl Chloride
The therapeutic efficacy of Ethyl chloride can be increased when used in combination with Pregabalin.
Ethyl Loflazepate
The therapeutic efficacy of Ethyl loflazepate can be increased when used in combination with Pregabalin.
Ethylmorphine
The therapeutic efficacy of Ethylmorphine can be increased when used in combination with Pregabalin.
Etidocaine
The therapeutic efficacy of Etidocaine can be increased when used in combination with Pregabalin.
Etifoxine
The therapeutic efficacy of Etifoxine can be increased when used in combination with Pregabalin.
Etomidate
The therapeutic efficacy of Etomidate can be increased when used in combination with Pregabalin.
Exenatide
The risk or severity of heart failure can be increased when Pregabalin is combined with Exenatide.
Ezogabine
The therapeutic efficacy of Ezogabine can be decreased when used in combination with Pregabalin.
Felbamate
The therapeutic efficacy of Felbamate can be decreased when used in combination with Pregabalin.
Fentanyl
The therapeutic efficacy of Fentanyl can be increased when used in combination with Pregabalin.
Fexofenadine
The therapeutic efficacy of Fexofenadine can be increased when used in combination with Pregabalin.
Flibanserin
The therapeutic efficacy of Flibanserin can be increased when used in combination with Pregabalin.
Flunarizine
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Pregabalin.
Flunitrazepam
The therapeutic efficacy of Flunitrazepam can be increased when used in combination with Pregabalin.
Fluoxetine
The risk or severity of adverse effects can be increased when Pregabalin is combined with Fluoxetine.
Flupenthixol
The therapeutic efficacy of Flupentixol can be increased when used in combination with Pregabalin.
Fluphenazine
The therapeutic efficacy of Fluphenazine can be increased when used in combination with Pregabalin.
Flurazepam
The therapeutic efficacy of Flurazepam can be increased when used in combination with Pregabalin.
Fluspirilene
The therapeutic efficacy of Fluspirilene can be increased when used in combination with Pregabalin.
Fluticasone propionate
The therapeutic efficacy of Fluticasone propionate can be increased when used in combination with Pregabalin.
Fluvoxamine
The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Pregabalin.
Fosinopril
The risk or severity of angioedema can be increased when Fosinopril is combined with Pregabalin.
Fosphenytoin
The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Pregabalin.
Fospropofol
The therapeutic efficacy of Fospropofol can be increased when used in combination with Pregabalin.
Gabapentin
The therapeutic efficacy of Gabapentin can be decreased when used in combination with Pregabalin.
Gabapentin Enacarbil
The therapeutic efficacy of Gabapentin Enacarbil can be increased when used in combination with Pregabalin.
Glibornuride
The risk or severity of heart failure can be increased when Pregabalin is combined with Glibornuride.
Gliclazide
The risk or severity of heart failure can be increased when Pregabalin is combined with Gliclazide.
Glimepiride
The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.
Glipizide
The risk or severity of heart failure can be increased when Pregabalin is combined with Glipizide.
Gliquidone
The risk or severity of heart failure can be increased when Pregabalin is combined with Gliquidone.
Glutethimide
The therapeutic efficacy of Glutethimide can be increased when used in combination with Pregabalin.
Glyburide
The risk or severity of heart failure can be increased when Pregabalin is combined with Glyburide.
Guanfacine
The therapeutic efficacy of Guanfacine can be increased when used in combination with Pregabalin.
Halazepam
The therapeutic efficacy of Halazepam can be increased when used in combination with Pregabalin.
Haloperidol
The therapeutic efficacy of Haloperidol can be increased when used in combination with Pregabalin.
Halothane
The therapeutic efficacy of Halothane can be increased when used in combination with Pregabalin.
Heroin
The therapeutic efficacy of Heroin can be increased when used in combination with Pregabalin.
Hexobarbital
The therapeutic efficacy of Hexobarbital can be increased when used in combination with Pregabalin.
Hydrocodone
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The therapeutic efficacy of Hydromorphone can be increased when used in combination with Pregabalin.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Ifenprodil
The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Pregabalin.
Iloperidone
The therapeutic efficacy of Iloperidone can be increased when used in combination with Pregabalin.
Imidapril
The risk or severity of angioedema can be increased when Imidapril is combined with Pregabalin.
Imipramine
The therapeutic efficacy of Imipramine can be increased when used in combination with Pregabalin.
Insulin Detemir
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Detemir.
Insulin Glargine
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Glargine.
insulin human, rDNA origin
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Human.
Insulin Lispro
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Lispro.
Insulin, Aspart Protamine, Human
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Aspart.
Insulin, Aspart, Human
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Aspart.
Insulin, Glulisine, Human
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Glulisine.
Insulin, Pork
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Pork.
Insulin, Protamine Lispro, Human
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Lispro.
Insulin, Regular, Pork
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Pork.
Isocarboxazid
The therapeutic efficacy of Pregabalin can be increased when used in combination with Isocarboxazid.
Isoflurane
The therapeutic efficacy of Isoflurane can be increased when used in combination with Pregabalin.
Ketamine
The therapeutic efficacy of Ketamine can be increased when used in combination with Pregabalin.
Ketazolam
The therapeutic efficacy of Ketazolam can be increased when used in combination with Pregabalin.
Lacosamide
The therapeutic efficacy of Lacosamide can be decreased when used in combination with Pregabalin.
Lamotrigine
The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Pregabalin.
Levetiracetam
The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Pregabalin.
Levobupivacaine
The therapeutic efficacy of Levobupivacaine can be increased when used in combination with Pregabalin.
Levocabastine
The therapeutic efficacy of Levocabastine can be increased when used in combination with Pregabalin.
Levocetirizine
The therapeutic efficacy of Levocetirizine can be increased when used in combination with Pregabalin.
Levodopa
The therapeutic efficacy of Levodopa can be increased when used in combination with Pregabalin.
Levomethadyl
The therapeutic efficacy of Levomethadyl Acetate can be increased when used in combination with Pregabalin.
Levomilnacipran
The risk or severity of adverse effects can be increased when Pregabalin is combined with Levomilnacipran.
Levorphanol
The therapeutic efficacy of Levorphanol can be increased when used in combination with Pregabalin.
Lidocaine
The therapeutic efficacy of Lidocaine can be increased when used in combination with Pregabalin.
Linagliptin
The risk or severity of heart failure can be increased when Pregabalin is combined with Linagliptin.
Liraglutide
The risk or severity of heart failure can be increased when Pregabalin is combined with Liraglutide.
Lisinopril
The risk or severity of angioedema can be increased when Lisinopril is combined with Pregabalin.
Lisinopril Anhydrous
The risk or severity of angioedema can be increased when Lisinopril is combined with Pregabalin.
Lithium
The therapeutic efficacy of Lithium can be increased when used in combination with Pregabalin.
Lithium Cation
The therapeutic efficacy of Lithium can be increased when used in combination with Pregabalin.
Loratadine
The therapeutic efficacy of Loratadine can be increased when used in combination with Pregabalin.
Lorazepam
The therapeutic efficacy of Lorazepam can be decreased when used in combination with Pregabalin.
Lormetazepam
The therapeutic efficacy of Lormetazepam can be increased when used in combination with Pregabalin.
Loxapine
The therapeutic efficacy of Loxapine can be increased when used in combination with Pregabalin.
Lurasidone
The therapeutic efficacy of Lurasidone can be increased when used in combination with Pregabalin.
Magnesium Sulfate
The therapeutic efficacy of Pregabalin can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Pregabalin can be increased when used in combination with Magnesium sulfate.
Maprotiline
The therapeutic efficacy of Maprotiline can be increased when used in combination with Pregabalin.
Mebeverine
The therapeutic efficacy of Mebeverine can be decreased when used in combination with Pregabalin.
Meclizine
The therapeutic efficacy of Meclizine can be increased when used in combination with Pregabalin.
Mefloquine
The therapeutic efficacy of Pregabalin can be decreased when used in combination with Mefloquine.
Melatonin
The therapeutic efficacy of Melatonin can be increased when used in combination with Pregabalin.
Meperidine
The therapeutic efficacy of Pethidine can be increased when used in combination with Pregabalin.
Mephenytoin
The therapeutic efficacy of Mephenytoin can be decreased when used in combination with Pregabalin.
Mephobarbital
The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Pregabalin.
Mepivacaine
The therapeutic efficacy of Mepivacaine can be increased when used in combination with Pregabalin.
Meprobamate
The therapeutic efficacy of Meprobamate can be decreased when used in combination with Pregabalin.
Mesoridazine
The therapeutic efficacy of Mesoridazine can be increased when used in combination with Pregabalin.
Metaxalone
The therapeutic efficacy of Metaxalone can be increased when used in combination with Pregabalin.
Metformin
The risk or severity of heart failure can be increased when Pregabalin is combined with Metformin.
Methadone
The therapeutic efficacy of Methadone can be increased when used in combination with Pregabalin.
Methadyl Acetate
The therapeutic efficacy of Methadyl Acetate can be increased when used in combination with Pregabalin.
Methapyrilene
The therapeutic efficacy of Methapyrilene can be increased when used in combination with Pregabalin.
Methaqualone
The therapeutic efficacy of Methaqualone can be increased when used in combination with Pregabalin.
Metharbital
The therapeutic efficacy of Metharbital can be decreased when used in combination with Pregabalin.
Methocarbamol
The therapeutic efficacy of Methocarbamol can be increased when used in combination with Pregabalin.
Methohexital
The therapeutic efficacy of Methohexital can be increased when used in combination with Pregabalin.
Methotrimeprazine
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The therapeutic efficacy of Methoxyflurane can be increased when used in combination with Pregabalin.
Methsuximide
The therapeutic efficacy of Methsuximide can be decreased when used in combination with Pregabalin.
Metylperon
The therapeutic efficacy of Melperone can be increased when used in combination with Pregabalin.
Metyrosine
Pregabalin may increase the sedative activities of Metyrosine.
Mianserin
The therapeutic efficacy of Pregabalin can be decreased when used in combination with Mianserin.
Midazolam
The therapeutic efficacy of Midazolam can be increased when used in combination with Pregabalin.
Miglitol
The risk or severity of heart failure can be increased when Pregabalin is combined with Miglitol.
Miglustat
The risk or severity of heart failure can be increased when Pregabalin is combined with Miglustat.
Milnacipran
The risk or severity of adverse effects can be increased when Pregabalin is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Mirtazapine
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moexipril
The risk or severity of angioedema can be increased when Moexipril is combined with Pregabalin.
Molindone
The therapeutic efficacy of Molindone can be increased when used in combination with Pregabalin.
Morphine
The therapeutic efficacy of Morphine can be increased when used in combination with Pregabalin.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Nalbuphine
The therapeutic efficacy of Nalbuphine can be increased when used in combination with Pregabalin.
Nateglinide
The risk or severity of heart failure can be increased when Pregabalin is combined with Nateglinide.
Nefazodone
The risk or severity of adverse effects can be increased when Pregabalin is combined with Nefazodone.
Nitrazepam
The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Pregabalin.
Nitrous Oxide
The therapeutic efficacy of Nitrous oxide can be increased when used in combination with Pregabalin.
Norflurane
The therapeutic efficacy of Norflurane can be increased when used in combination with Pregabalin.
Normethadone
The therapeutic efficacy of Normethadone can be increased when used in combination with Pregabalin.
Nortriptyline
The therapeutic efficacy of Nortriptyline can be increased when used in combination with Pregabalin.
Olanzapine
The therapeutic efficacy of Olanzapine can be increased when used in combination with Pregabalin.
Olopatadine
The therapeutic efficacy of Olopatadine can be increased when used in combination with Pregabalin.
Ondansetron
The therapeutic efficacy of Ondansetron can be increased when used in combination with Pregabalin.
Opium
The therapeutic efficacy of Opium can be increased when used in combination with Pregabalin.
Orlistat
The serum concentration of Pregabalin can be decreased when it is combined with Orlistat.
Orphenadrine
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The therapeutic efficacy of Oxazepam can be increased when used in combination with Pregabalin.
Oxcarbazepine
The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Pregabalin.
Oxprenolol
The therapeutic efficacy of Oxprenolol can be increased when used in combination with Pregabalin.
Oxycodone
The therapeutic efficacy of Oxycodone can be increased when used in combination with Pregabalin.
Oxymorphone
The therapeutic efficacy of Oxymorphone can be increased when used in combination with Pregabalin.
Paliperidone
The therapeutic efficacy of Paliperidone can be increased when used in combination with Pregabalin.
Paraldehyde
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paramethadione
The therapeutic efficacy of Paramethadione can be decreased when used in combination with Pregabalin.
Paregoric
The therapeutic efficacy of Morphine can be increased when used in combination with Pregabalin.
Paroxetine
The risk or severity of adverse effects can be increased when Pregabalin is combined with Paroxetine.
Pentazocine
The therapeutic efficacy of Pentazocine can be increased when used in combination with Pregabalin.
Pentobarbital
The therapeutic efficacy of Pentobarbital can be increased when used in combination with Pregabalin.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Perazine
The therapeutic efficacy of Perazine can be increased when used in combination with Pregabalin.
Perindopril
The risk or severity of angioedema can be increased when Perindopril is combined with Pregabalin.
Perphenazine
The therapeutic efficacy of Perphenazine can be increased when used in combination with Pregabalin.
Phenacemide
The therapeutic efficacy of Phenacemide can be decreased when used in combination with Pregabalin.
Phenformin
The risk or severity of heart failure can be increased when Pregabalin is combined with Phenformin.
Phenobarbital
The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Pregabalin.
Phenoxyethanol
The therapeutic efficacy of Phenoxyethanol can be increased when used in combination with Pregabalin.
Phensuximide
The therapeutic efficacy of Phensuximide can be decreased when used in combination with Pregabalin.
Phenytoin
The therapeutic efficacy of Phenytoin can be decreased when used in combination with Pregabalin.
Pimozide
The therapeutic efficacy of Pimozide can be increased when used in combination with Pregabalin.
Pioglitazone
The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.
Pipamperone
The therapeutic efficacy of Pipamperone can be increased when used in combination with Pregabalin.
Pipothiazine
The therapeutic efficacy of Pipotiazine can be increased when used in combination with Pregabalin.
Pirinitramide
The therapeutic efficacy of Piritramide can be increased when used in combination with Pregabalin.
Pizotyline
The therapeutic efficacy of Pizotifen can be increased when used in combination with Pregabalin.
Pomalidomide
The therapeutic efficacy of Pomalidomide can be increased when used in combination with Pregabalin.
Pramipexole
Pregabalin may increase the sedative activities of Pramipexole.
Pramlintide
The risk or severity of heart failure can be increased when Pregabalin is combined with Pramlintide.
Pramoxine
The therapeutic efficacy of Pramocaine can be increased when used in combination with Pregabalin.
Prazepam
The therapeutic efficacy of Prazepam can be increased when used in combination with Pregabalin.
Prilocaine
The therapeutic efficacy of Prilocaine can be increased when used in combination with Pregabalin.
Primidone
The therapeutic efficacy of Primidone can be decreased when used in combination with Pregabalin.
Procaine
The therapeutic efficacy of Procaine can be increased when used in combination with Pregabalin.
Prochlorperazine
The therapeutic efficacy of Prochlorperazine can be increased when used in combination with Pregabalin.
Progabide
The therapeutic efficacy of Progabide can be decreased when used in combination with Pregabalin.
Promazine
The therapeutic efficacy of Promazine can be increased when used in combination with Pregabalin.
Promethazine
The therapeutic efficacy of Promethazine can be increased when used in combination with Pregabalin.
Proparacaine
The therapeutic efficacy of Proparacaine can be increased when used in combination with Pregabalin.
Propofol
The therapeutic efficacy of Propofol can be increased when used in combination with Pregabalin.
Propoxyphene
The therapeutic efficacy of Dextropropoxyphene can be increased when used in combination with Pregabalin.
Protriptyline
The therapeutic efficacy of Protriptyline can be increased when used in combination with Pregabalin.
Quazepam
The therapeutic efficacy of Quazepam can be increased when used in combination with Pregabalin.
Quetiapine
The therapeutic efficacy of Quetiapine can be increased when used in combination with Pregabalin.
Quetiapine fumarate
The therapeutic efficacy of Quetiapine can be increased when used in combination with Pregabalin.
Quinapril
The risk or severity of angioedema can be increased when Quinapril is combined with Pregabalin.
Ramelteon
The therapeutic efficacy of Ramelteon can be increased when used in combination with Pregabalin.
Ramipril
The risk or severity of angioedema can be increased when Ramipril is combined with Pregabalin.
Regular Insulin, Human
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Human.
Remifentanil
The therapeutic efficacy of Remifentanil can be increased when used in combination with Pregabalin.
Remoxipride
The therapeutic efficacy of Remoxipride can be increased when used in combination with Pregabalin.
Repaglinide
The risk or severity of heart failure can be increased when Pregabalin is combined with Repaglinide.
Rescinnamine
The risk or severity of angioedema can be increased when Rescinnamine is combined with Pregabalin.
Reserpine
The therapeutic efficacy of Reserpine can be increased when used in combination with Pregabalin.
Riluzole
The therapeutic efficacy of Riluzole can be decreased when used in combination with Pregabalin.
Risperidone
The therapeutic efficacy of Risperidone can be increased when used in combination with Pregabalin.
Ropinirole
Pregabalin may increase the sedative activities of Ropinirole.
Ropivacaine
The therapeutic efficacy of Ropivacaine can be increased when used in combination with Pregabalin.
Rosiglitazone
The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.
Rotigotine
Pregabalin may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Pregabalin.
Saxagliptin
The risk or severity of heart failure can be increased when Pregabalin is combined with Saxagliptin.
Saxagliptin Anhydrous
The risk or severity of heart failure can be increased when Pregabalin is combined with Saxagliptin.
Scopolamine
The therapeutic efficacy of Scopolamine can be increased when used in combination with Pregabalin.
Scopolamine Hydrobromide
The therapeutic efficacy of Scopolamine can be increased when used in combination with Pregabalin.
Secobarbital
The therapeutic efficacy of Secobarbital can be increased when used in combination with Pregabalin.
Sertindole
The therapeutic efficacy of Sertindole can be increased when used in combination with Pregabalin.
Sertraline
The risk or severity of adverse effects can be increased when Pregabalin is combined with Sertraline.
Sevoflurane
The therapeutic efficacy of Sevoflurane can be increased when used in combination with Pregabalin.
Sitagliptin
The risk or severity of heart failure can be increased when Pregabalin is combined with Sitagliptin.
Sitagliptin Phosphate
The risk or severity of heart failure can be increased when Pregabalin is combined with Sitagliptin.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Spirapril
The risk or severity of angioedema can be increased when Spirapril is combined with Pregabalin.
Sufentanil
The therapeutic efficacy of Sufentanil can be increased when used in combination with Pregabalin.
Sulpiride
The therapeutic efficacy of Sulpiride can be increased when used in combination with Pregabalin.
Sulthiame
The therapeutic efficacy of Sulthiame can be decreased when used in combination with Pregabalin.
Suvorexant
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Tasimelteon
The therapeutic efficacy of Tasimelteon can be increased when used in combination with Pregabalin.
Temazepam
The therapeutic efficacy of Temazepam can be increased when used in combination with Pregabalin.
Tetrabenazine
The therapeutic efficacy of Tetrabenazine can be increased when used in combination with Pregabalin.
Tetracaine
The therapeutic efficacy of Tetracaine can be increased when used in combination with Pregabalin.
Tetracaine hydrochloride
The therapeutic efficacy of Tetracaine can be increased when used in combination with Pregabalin.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Thalidomide
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The therapeutic efficacy of Thiamylal can be increased when used in combination with Pregabalin.
Thiopental
The therapeutic efficacy of Thiopental can be decreased when used in combination with Pregabalin.
Thiopental Sodium
The therapeutic efficacy of Thiopental can be decreased when used in combination with Pregabalin.
Thioridazine
The therapeutic efficacy of Thioridazine can be increased when used in combination with Pregabalin.
Thiothixene
The therapeutic efficacy of Thiothixene can be increased when used in combination with Pregabalin.
Tiagabine
The therapeutic efficacy of Tiagabine can be decreased when used in combination with Pregabalin.
Tiapride
The therapeutic efficacy of Tiapride can be increased when used in combination with Pregabalin.
Tizanidine
The therapeutic efficacy of Tizanidine can be decreased when used in combination with Pregabalin.
Tolazamide
The risk or severity of heart failure can be increased when Pregabalin is combined with Tolazamide.
Tolbutamide
The risk or severity of heart failure can be increased when Pregabalin is combined with Tolbutamide.
Tolcapone
The therapeutic efficacy of Tolcapone can be increased when used in combination with Pregabalin.
Topiramate
The therapeutic efficacy of Topiramate can be decreased when used in combination with Pregabalin.
Tramadol
The therapeutic efficacy of Tramadol can be increased when used in combination with Pregabalin.
Tramiprosate
The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Pregabalin.
Trandolapril
The risk or severity of angioedema can be increased when Trandolapril is combined with Pregabalin.
Tranylcypromine
The therapeutic efficacy of Tranylcypromine can be increased when used in combination with Pregabalin.
Trazodone
The therapeutic efficacy of Trazodone can be increased when used in combination with Pregabalin.
Triazolam
The therapeutic efficacy of Triazolam can be increased when used in combination with Pregabalin.
Triazulenone
The therapeutic efficacy of Loprazolam can be increased when used in combination with Pregabalin.
Trifluoperazine
The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Pregabalin.
Triflupromazine
The therapeutic efficacy of Triflupromazine can be increased when used in combination with Pregabalin.
Trimethadione
The therapeutic efficacy of Trimethadione can be decreased when used in combination with Pregabalin.
Trimipramine
The therapeutic efficacy of Trimipramine can be increased when used in combination with Pregabalin.
Triprolidine
The therapeutic efficacy of Triprolidine can be increased when used in combination with Pregabalin.
Troglitazone
The risk or severity of heart failure can be increased when Pregabalin is combined with Troglitazone.
Urethane
The therapeutic efficacy of Ethyl carbamate can be increased when used in combination with Pregabalin.
Valproate
The therapeutic efficacy of Valproic Acid can be decreased when used in combination with Pregabalin.
Valproic Acid
The therapeutic efficacy of Valproic Acid can be decreased when used in combination with Pregabalin.
Venlafaxine
The risk or severity of adverse effects can be increased when Pregabalin is combined with Venlafaxine.
Vigabatrin
The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Pregabalin.
Vildagliptin
The risk or severity of heart failure can be increased when Pregabalin is combined with Vildagliptin.
Vinpocetine
The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Pregabalin.
Vortioxetine
The therapeutic efficacy of Vortioxetine can be increased when used in combination with Pregabalin.
Yohimbine
The therapeutic efficacy of Pregabalin can be decreased when used in combination with Yohimbine.
Zaleplon
The therapeutic efficacy of Zaleplon can be decreased when used in combination with Pregabalin.
Ziconotide
The therapeutic efficacy of Ziconotide can be increased when used in combination with Pregabalin.
Ziprasidone
The therapeutic efficacy of Ziprasidone can be increased when used in combination with Pregabalin.
Zofenopril
The risk or severity of angioedema can be increased when Zofenopril is combined with Pregabalin.
Zolpidem
Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The therapeutic efficacy of Zonisamide can be decreased when used in combination with Pregabalin.
Zopiclone
The therapeutic efficacy of Zopiclone can be increased when used in combination with Pregabalin.
Zotepine
The therapeutic efficacy of Zotepine can be increased when used in combination with Pregabalin.
Zuclopenthixol
The therapeutic efficacy of Zuclopenthixol can be increased when used in combination with Pregabalin.
